XML 62 R24.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Shareholders' Equity | 12 Months Ended
--- | ---
Dec. 31, 2017
Equity [Abstract] |
Shareholders' Equity |
| 16. | SHAREHOLDERS’ EQUITY
16.1 Outstanding shares The authorized share capital of the Company is Euro 1,810 million consisting of 1,200,000,000 common shares and 540,000,000 preference shares, each with a nominal value of €1.04. As at December 31, 2017 the number of shares of common stock issued was 911,110,420 shares (911,030,420 at December 31, 2016). As of December 31, 2017 the number of shares of common stock outstanding was 896,590,286 (883,410,506 at December 31, 2016). 16.2 Preference shares The 540,000,000 preference shares, when issued, will entitle a holder to full voting rights and to a preferential right to dividends and distributions upon liquidation. On January 22, 2007, an option agreement was concluded between the Company and Stichting Continuïteit ST. This option agreement provides for the issuance of 540,000,000 preference shares. The Foundation can acquire preference shares upon payment of at least 25% of the par value of the preference shares to be issued in the event of actions which the board of the Foundation determines would be contrary to our interests, our shareholders and our other stakeholders and which in the event of a creeping acquisition or offer for our common shares are not supported by our Managing Board and Supervisory Board. The preference shares may remain outstanding for no longer than two years. In October 2016, the Company extended for another 10-year period the existing option agreement with Stichting Continuiteït ST. There were no preference shares issued as of December 31, 2017 and December 31, 2016 respectively. 16.3 Treasury stock Following the authorization by the Supervisory Board, announced on April 2, 2008, the Company acquired 29.5 million shares of its common stock in 2008, reflected at cost, as a reduction of the parent company stockholders’ equity. Pursuant to a resolution passed at the shareholders’ meeting held on June 13, 2014, the Company repurchased 20.0 million shares of its common stock in 2014 under the buy-back program, reflected at cost, as a reduction of the parent company stockholders’ equity. Additionally, pursuant to a resolution passed at the shareholders’ meeting held on June 20, 2017 and announced on June 22, 2017, the Company repurchased 18.6 million shares of its common stock for a total of $297 million under the share buy-back program, reflected at cost, as a reduction of the parent company stockholders’ equity. In the second half of 2017, the Company delivered 26.8 million shares from its treasury shares following the conversion of the Tranche A and Tranche B of the convertible bonds issued on July 3, 2014. The treasury shares have been designated for allocation under the Company’s share based remuneration programs of unvested shares. As of December 31, 2017, 40,198,271 of these treasury shares were transferred to employees under the Company’s share based remuneration programs, of which 4,897,965 in the year ended December 31, 2017. As of December 31, 2017, the Company owned a number of treasury shares equivalent to 14,520,134 compared to 27,619,914 as of December 31, 2016. 16.4 Unvested share awards for the Supervisory Board On an annual basis and until the year 2012, the Compensation Committee (on behalf of the Supervisory Board and with its approval) used to grant stock-based awards (the options to acquire common shares in the share capital of the Company) to the members and professionals of the Supervisory Board (“The Supervisory Board Plan”). The awards were granted at the nominal value of the share of €1.04 (exercise price of the option). The options granted under the Supervisory Board Plan vest and become exercisable immediately, while the shares resulting from these awards vest and therefore become available for trade evenly over three years (one third every year), with no market, performance or service conditions. The table below summarizes grants under the outstanding stock award plans as authorized by the Compensation Committee:
Year of grant |  | Options granted and vested |  |  | Options waived at grant |
2005 |  |  | 66,000 |  |  |  | (15,000 | )
2006 |  |  | 66,000 |  |  |  | (15,000 | )
2007 |  |  | 165,000 |  |  |  | (22,500 | )
2008 |  |  | 165,000 |  |  |  | (22,500 | )
2009 |  |  | 165,000 |  |  |  | (7,500 | )
2010 |  |  | 172,500 |  |  |  | (7,500 | )
2011 |  |  | 172,500 |  |  |  | (30,000 | )
2012 |  |  | 180,000 |  |  |  | (22,500 | )
2013 |  |  | No options granted |
2014 |  |  | No options granted |
2015 |  |  | No options granted |
2016 |  |  | No options granted |
2017 |  |  | No options granted |
A summary of the options’ activity by plan for the years ended December 31, 2017 and December 31, 2016 is presented below:
Year of grant |  | Outstanding as of 31.12.2015 |  |  | Exercised |  |  | Expired / Cancelled |  |  | Outstanding as of 31.12.2016 |  |  | Exercised |  |  | Expired / Cancelled |  |  | Outstanding as of 31.12.2017 |
2006 |  |  | 3,000 |  |  |  | (3,000 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
2007 |  |  | 19,500 |  |  |  | (12,000 | ) |  |  | — |  |  |  | 7,500 |  |  |  | (7,500 | ) |  |  | — |  |  |  | — |
2008 |  |  | 39,000 |  |  |  | (15,000 | ) |  |  | — |  |  |  | 24,000 |  |  |  | (7,500 | ) |  |  | — |  |  |  | 16,500 |
2009 |  |  | 45,000 |  |  |  | (10,000 | ) |  |  | — |  |  |  | 35,000 |  |  |  | (12,500 | ) |  |  | — |  |  |  | 22,500 |
2010 |  |  | 45,000 |  |  |  | — |  |  |  | — |  |  |  | 45,000 |  |  |  | (15,000 | ) |  |  | — |  |  |  | 30,000 |
2011 |  |  | 82,500 |  |  |  | (15,000 | ) |  |  | — |  |  |  | 67,500 |  |  |  | (15,000 | ) |  |  | — |  |  |  | 52,500 |
2012 |  |  | 95,000 |  |  |  | (7,500 | ) |  |  | — |  |  |  | 87,500 |  |  |  | (22,500 | ) |  |  | — |  |  |  | 65,000 |
The total intrinsic value of options exercised during the year 2017 amounted to $1 million compared to less than $1 million for the year 2016 and $1 million for the year 2015. The total intrinsic value of options outstanding as of December 31, 2017 amounted to $4 million. At the Company’s Annual General Meeting of Shareholders held on 21 June 2013, it was resolved to abolish and terminate the stock-based compensation for the Supervisory Board members and professionals. 16.5 Unvested share awards for the employees On an annual basis, the Compensation Committee (on behalf of the Supervisory Board and with its approval) grants stock-based awards to the senior executives along with selected employees (the “Employee Plan”). The awards are granted for services under the Employee Plan. There are two types of unvested shares: (1) shares granted to employees, which are subject only to service conditions and vest over the requisite service period, and (2) shares granted to senior executives, whose vesting is subject to performance conditions. For the plans 2013, 2014, 2015 and 2017, the performance conditions consisted of two external targets (sales evolution and operating income compared to a basket of competitors) weighting for two third of the total number of awards granted and of one internal target (cash flow compared to budget for the plans 2013 and 2014 and return on net assets compared to budget for the plans 2015 and 2017), weighting for one third of the total number of awards granted. For the plan 2016, the performance conditions consisted of two external targets (sales evolution and operating income compared to a basket of competitors) weighting for 80% of the total number of awards granted and of two internal targets (days of sales outstanding compared to the budget and return on net assets compared to budget), weighting for 20% of the total number of awards granted. All the awards vest over a three year service period (32% as of the first anniversary of the grant, 32% as of the second anniversary of the grant and 36% as of the third anniversary of the grant). In addition, in 2013, 2014, 2015 and 2016 there was a Special Bonus granted to the Company’s CEO. The table below summarizes grants under the outstanding stock award plans as authorized by the Compensation Committee:
Date of grant |  | Plan name |  | Number of shares granted |  |  | Number of shares waived |  |  | Number of shares lost on performance conditions |
July 22, 2013 |  | 2013 CEO Special Bonus |  |  | 63,848 |  |  |  | — |  |  |  | — |
July 22, 2014 |  | 2014 CEO Special Bonus |  |  | 34,483 |  |  |  | — |  |  |  | — |
July 22, 2014 |  | 2014 Employee Plan |  |  | 6,458,435 |  |  |  | — |  |  |  | (1,939,222 | )
December 18, 2014 |  | 2014 Employee Plan |  |  | 500,775 |  |  |  | — |  |  |  | (31,332 | )
March 24, 2015 |  | 2015 CEO Special Bonus |  |  | 53,369 |  |  |  | — |  |  |  | — |
July 27, 2015 |  | 2015 Employee Plan |  |  | 6,591,200 |  |  |  | — |  |  |  | (1,961,886 | )
December 15, 2015 |  | 2015 Employee Plan |  |  | 370,920 |  |  |  | — |  |  |  | (29,078 | )
April 26, 2016 |  | 2016 CEO Special Bonus |  |  | 69,165 |  |  |  | — |  |  |  | — |
July 26, 2016 |  | 2016 Employee Plan |  |  | 6,621,100 |  |  |  | — |  |  |  | (1,628,376 | )
December 19, 2016 |  | 2016 Employee Plan |  |  | 376,800 |  |  |  | — |  |  |  | (53,900 | )
July 25, 2017 |  | 2017 Employee Plan |  |  | 7,634,475 |  |  |  | — |  |  |  | ( | *)
December 22, 2017 |  | 2017 Employee Plan |  |  | 347,160 |  |  |  | — |  |  |  | ( | *)
(*) | As at December 31, 2017, a final determination of the achievement of the performance conditions had not yet been made by the Compensation Committee of the Supervisory Board.
A summary of the unvested share activity by plan for the year ended December 31, 2017 is presented below:
Unvested Shares |  | Unvested as at December 31, 2016 |  |  | Granted |  |  | Forfeited / waived |  |  | Cancelled on failed vesting conditions |  |  | Vested |  |  | Unvested as at December 31, 2017 |
2013 CEO Special Bonus |  |  | 7,095 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (7,095 | ) |  |  | — |
2014 CEO Special Bonus |  |  | 11,495 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (11,495 | ) |  |  | — |
2014 Employee Plan |  |  | 1,611,453 |  |  |  | — |  |  |  | (7,253 | ) |  |  | — |  |  |  | (1,604,200 | ) |  |  | — |
2015 CEO Special Bonus |  |  | 35,579 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (17,790 | ) |  |  | 17,789 |
2015 Employee Plan |  |  | 3,170,739 |  |  |  | — |  |  |  | (24,694 | ) |  |  | — |  |  |  | (1,515,261 | ) |  |  | 1,630,784 |
2016 CEO Special Bonus |  |  | — |  |  |  | 69,165 |  |  |  | — |  |  |  | — |  |  |  | (23,055 | ) |  |  | 46,110 |
2016 Employee Plan |  |  | 6,974,420 |  |  |  | — |  |  |  | (62,179 | ) |  |  | (1,682,276 | ) |  |  | (1,717,119 | ) |  |  | 3,512,846 |
2017 Employee Plan |  |  | — |  |  |  | 7,981,635 |  |  |  | (32,175 | ) |  |  | — |  |  |  | (1,950 | ) |  |  | 7,947,510 |
Total |  |  | 11,810,781 |  |  |  | 8,050,800 |  |  |  | (126,301 | ) |  |  | (1,682,276 | ) |  |  | (4,897,965 | ) |  |  | 13,155,039 |
The grant date fair value of unvested shares granted to the CEO under the 2013 CEO Special Bonus Plan was $9.35. On the 2013 CEO Special Bonus Plan, the fair value of the unvested shares granted reflected the market price of the shares at the date of the grant. The grant date fair value of unvested shares granted to the CEO under the 2014 CEO Special Bonus Plan was $9.35. On the 2014 CEO Special Bonus Plan, the fair value of the unvested shares granted reflected the market price of the shares at the date of the grant. The grant date weighted average fair value of unvested shares granted to employees under the 2014 Employee Plan was $9.23. On March 24, 2015, the Compensation Committee approved the statement that with respect to the shares subject to performance conditions, one performance condition was fully met. Consequently, the compensation expense recorded on the 2014 Employee Plan reflects the statement that — for the portion of shares subject to performance conditions — one third of the awards granted will fully vest, as far as the service condition is met. The grant date fair value of unvested shares granted to the CEO under the 2015 CEO Special Bonus Plan was $9.78. On the 2015 CEO Special Bonus Plan, the fair value of the unvested shares granted reflected the market price of the shares at the date of the grant. The grant date fair value of unvested shares granted to employees under the 2015 Employee Plan was $7.62. On April 26, 2016, the Compensation Committee approved the statement that with respect to the shares subject to performance conditions, one performance condition was fully met. Consequently, the compensation expense recorded on the 2015 Employee Plan reflects the statement that — for the portion of shares subject to performance conditions — one third of the awards granted will fully vest, as far as the service condition is met. The grant date fair value of unvested shares granted to the CEO under the 2016 CEO Special Bonus Plan was $5.36. On the 2016 CEO Special Bonus Plan, the fair value of the unvested shares granted reflected the market price of the shares at the date of the grant. The grant date weighted average fair value of unvested shares granted to employees under the 2016 Employee Plan was $6.37. On March 31, 2017, the Compensation Committee approved the statement that with respect to the shares subject to performance conditions, two performance conditions were fully met. Consequently, the compensation expense recorded on the 2016 Employee Plan reflects the statement that — for the portion of shares subject to performance conditions — 45% of the awards granted, representing the weight of the two performance conditions met, will fully vest, as far as the service condition is met. The grant date weighted average fair value of unvested shares granted to employees under the 2017 Employee Plan was $16.52. Moreover, for the portion of the shares subject to performance conditions (3,478,585 shares) the Company estimates the number of awards expected to vest by assessing the probability of achieving the performance conditions. At December 31, 2017, a final determination of the achievement of the performance conditions had not yet been made by the Compensation Committee of the Supervisory Board. However, the Company has estimated that 100% of the awards subject to performance conditions are expected to vest. Consequently, the compensation expense recorded for the 2017 Employee Plan reflects the vesting of 100% of the awards granted with performance conditions, subject to the service condition being met. The assumption of the expected number of awards to be vested upon achievement of the performance conditions is subject to changes based on the final measurement of the conditions, which is expected to occur in the first half of 2018. The following table illustrates the classification of pre-payroll tax and social contribution stock-based compensation expense included in the consolidated statements of income for the years ended December 31, 2017, December 31, 2016 and December 31, 2015:
|  | December 31, 2017 |  |  | December 31, 2016 |  |  | December 31, 2015 |
Cost of sales |  |  | 12 |  |  |  | 7 |  |  |  | 7 |
Selling, general and administrative |  |  | 31 |  |  |  | 17 |  |  |  | 17 |
Research and development |  |  | 18 |  |  |  | 14 |  |  |  | 14 |
Total pre-payroll tax and social contribution compensation |  |  | 61 |  |  |  | 38 |  |  |  | 38 |
The fair value of the shares vested in 2017 was $38 million compared to $42 million for 2016 and $35 million for 2015. Compensation cost, excluding payroll tax and social contribution, capitalized as part of inventory was $3 million as of December 31, 2017, compared to $2 million as of December 31, 2016 and 2015. As of December 31, 2017 there was $102 million of total unrecognized compensation cost related to the grant of unvested shares, which is expected to be recognized over a weighted average period of approximately 10 months. The total deferred income tax benefit recognized in the consolidated statements of income related to unvested share-based compensation expense amounted to $3 million, $2 million and $2 million for the years ended December 31, 2017, 2016 and 2015, respectively. 16.6 Accumulated other comprehensive income (loss) attributable to parent company stockholders The table below details the changes in AOCI attributable to the company’s stockholders by component, net of tax, for the years ended December 31, 2017, 2016 and 2015:
|  | Gains (Losses) on Cash Flow Hedges |  |  | Gains (Losses) on Available- For-Sale Securities |  |  | Defined Benefit Pension Plan Items |  |  | Foreign Currency Translation Adjustments (“CTA”) |  |  | Total |
December 31, 2014 |  |  | (76 | ) |  |  | 2 |  |  |  | (170 | ) |  |  | 813 |  |  |  | 569 |
Cumulative tax impact |  |  | — |  |  |  | — |  |  |  | 44 |  |  |  | — |  |  |  | 44 |
December 31, 2014, net of tax |  |  | (76 | ) |  |  | 2 |  |  |  | (126 | ) |  |  | 813 |  |  |  | 613 |
OCI before reclassifications |  |  | (117 | ) |  |  | — |  |  |  | (2 | ) |  |  | (202 | ) |  |  | (321 | )
Amounts reclassified from AOCI |  |  | 170 |  |  |  | — |  |  |  | 12 |  |  |  | (10 | ) |  |  | 172 |
OCI for the year ended December 31, 2015 |  |  | 53 |  |  |  | — |  |  |  | 10 |  |  |  | (212 | ) |  |  | (149 | )
Cumulative tax impact |  |  | — |  |  |  | — |  |  |  | (4 | ) |  |  | — |  |  |  | (4 | )
OCI for the year ended December 31, 2015, net of tax |  |  | 53 |  |  |  | — |  |  |  | 6 |  |  |  | (212 | ) |  |  | (153 | )
December 31, 2015 |  |  | (23 | ) |  |  | 2 |  |  |  | (160 | ) |  |  | 601 |  |  |  | 420 |
Cumulative tax impact |  |  | — |  |  |  | — |  |  |  | 40 |  |  |  | — |  |  |  | 40 |
December 31, 2015, net of tax |  |  | (23 | ) |  |  | 2 |  |  |  | (120 | ) |  |  | 601 |  |  |  | 460 |
OCI before reclassifications |  |  | (33 | ) |  |  | — |  |  |  | (25 | ) |  |  | (57 | ) |  |  | (115 | )
Amounts reclassified from AOCI |  |  | 9 |  |  |  | — |  |  |  | 15 |  |  |  | — |  |  |  | 24 |
OCI for the year ended December 31, 2016 |  |  | (24 | ) |  |  | — |  |  |  | (10 | ) |  |  | (57 | ) |  |  | (91 | )
Cumulative tax impact |  |  | — |  |  |  | — |  |  |  | 2 |  |  |  | — |  |  |  | 2 |
OCI for the year ended December 31, 2016, net of tax |  |  | (24 | ) |  |  | — |  |  |  | (8 | ) |  |  | (57 | ) |  |  | (89 | )
December 31, 2016 |  |  | (47 | ) |  |  | 2 |  |  |  | (170 | ) |  |  | 544 |  |  |  | 329 |
Cumulative tax impact |  |  | — |  |  |  | — |  |  |  | 42 |  |  |  | — |  |  |  | 42 |
December 31, 2016, net of tax |  |  | (47 | ) |  |  | 2 |  |  |  | (128 | ) |  |  | 544 |  |  |  | 371 |
OCI before reclassifications |  |  | 122 |  |  |  | (2 | ) |  |  | (6 | ) |  |  | 224 |  |  |  | 338 |
Amounts reclassified from AOCI |  |  | (30 | ) |  |  | — |  |  |  | 10 |  |  |  | — |  |  |  | (20 | )
OCI for the year ended December 31, 2017 |  |  | 92 |  |  |  | (2 | ) |  |  | 4 |  |  |  | 224 |  |  |  | 318 |
Cumulative tax impact |  |  | — |  |  |  | — |  |  |  | (1 | ) |  |  | — |  |  |  | (1 | )
OCI for the year ended December 31, 2017, net of tax |  |  | 92 |  |  |  | (2 | ) |  |  | 3 |  |  |  | 224 |  |  |  | 317 |
December 31, 2017 |  |  | 45 |  |  |  | — |  |  |  | (166 | ) |  |  | 768 |  |  |  | 647 |
Cumulative tax impact |  |  | — |  |  |  | — |  |  |  | 41 |  |  |  | — |  |  |  | 41 |
December 31, 2017, net of tax |  |  | 45 |  |  |  | — |  |  |  | (125 | ) |  |  | 768 |  |  |  | 688 |
Items reclassified out of Accumulated Other Comprehensive Income for the years ended December 31, 2017, 2016 and 2015 are listed in the table below:
Details about AOCI components |  | Amounts reclassified from AOCI in the year ended December 31, 2017 |  |  | Amounts reclassified from AOCI in the year ended December 31, 2016 |  |  | Amounts reclassified from AOCI in the year ended December 31, 2015 |  |  | Affected line item in the statement where net income (loss) is presented
Gains (Losses) on Cash Flow Hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange derivative contracts |  |  | 16 |  |  |  | (7 | ) |  |  | (105 | ) |  | Cost of sales
Foreign exchange derivative contracts |  |  | 3 |  |  |  | — |  |  |  | (14 | ) |  | Selling, general and administrative
Foreign exchange derivative contracts |  |  | 11 |  |  |  | (2 | ) |  |  | (51 | ) |  | Research and development
|  |  | — |  |  |  | — |  |  |  | — |  |  | Income tax benefit (expense)
|  |  | 30 |  |  |  | (9 | ) |  |  | (170 | ) |  | Net of tax
Defined Benefit Pension Plan Items |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of actuarial gains (losses) |  |  | (1 | ) |  |  | (1 | ) |  |  | — |  |  | Cost of sales
Amortization of actuarial gains (losses) |  |  | (4 | ) |  |  | (8 | ) |  |  | (5 | ) |  | Selling, general and administrative
Amortization of actuarial gains (losses) |  |  | (5 | ) |  |  | (6 | ) |  |  | (6 | ) |  | Research and development
Amortization of prior service cost |  |  | — |  |  |  | — |  |  |  | (1 | ) |  | Research and development
|  |  | 2 |  |  |  | 4 |  |  |  | 4 |  |  | Income tax benefit (expense)
|  |  | (8 | ) |  |  | (11 | ) |  |  | (8 | ) |  | Net of tax
Foreign currency translation adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |
Realized gain on disposal of investments |  |  | — |  |  |  | — |  |  |  | 10 |  |  | Income (loss) on equity-method investments
|  |  | — |  |  |  | — |  |  |  | — |  |  | Income tax benefit (expense)
|  |  | — |  |  |  | — |  |  |  | 10 |  |  | Net of tax
Total reclassifications for the year |  |  | 22 |  |  |  | (20 | ) |  |  | (168 | ) |  |
Attributable to noncontrolling interest |  |  | — |  |  |  | — |  |  |  | — |  |  |
Attributable to the Company’s stockholders |  |  | 22 |  |  |  | (20 | ) |  |  | (168 | ) |  |
16.7 Dividends The Annual General Meeting of Shareholders held on June 20, 2017 authorized the distribution of a cash dividend of $0.24 per outstanding share of the Company’s common stock, to be distributed in quarterly installments of $0.06 in each of the second, third and fourth quarters of 2017 and first quarter of 2018. The amount of $53 million corresponding to the first installment, $53 million corresponding to the second installment and $47 million corresponding to the third installment were paid as of December 31, 2017. The remaining portion of the third installment amounting to $7 million and the last installment of $53 million are presented in the line “Dividends payable to stockholders” in the consolidated balance sheet as of December 31, 2017. The Annual General Meeting of Shareholders held on May 25, 2016 authorized the distribution of a cash dividend of $0.24 per outstanding share of the Company’s common stock, to be distributed in quarterly installments of $0.06 in each of the second, third and fourth quarters of 2016 and first quarter of 2017. The amount of $53 million corresponding to the first installment, $53 million corresponding to the second installment and $47 million corresponding to the third installment were paid as of December 31, 2016. The remaining portion of the third installment amounting to $6 million and the fourth installment of $53 million were paid in the first half of 2017. The Annual General Meeting of Shareholders held on May 27, 2015 authorized the distribution of a cash dividend of $0.40 per outstanding share of the Company’s common stock, to be distributed in quarterly installments of $0.10 in each of the second, third and fourth quarters of 2015 and first quarter of 2016. The amount of $88 million corresponding to the first installment, $88 million corresponding to the second installment and $78 million corresponding to the third installment were paid during 2015. The remaining portion of $9 million related to the third installment and the fourth installment of $88 million were paid in the first half of 2016. The Supervisory Board held on December 4, 2014 authorized the distribution of a semi-annual cash dividend per common share of $0.10 in the fourth quarter of 2014 and $0.10 in the first quarter of 2015, to be distributed in December 2014 and March 2015, respectively. The first installment of $87 million was paid in December 2014 and January 2015. The second installment of $87 million was paid in the first half of 2015.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration